NCT05442918

Brief Summary

The investigators propose a multicenter prospective study in patients undergoing either an elective bariatric procedure or an elective benign procedure, including laparoscopic/open cholecystectomy, laparoscopic/open hiatus hernia repair, laparoscopic/open inguinal hernia repair, laparoscopic/open umbilical hernia repair or laparoscopic ventral wall hernia repair. Perioperative blood ketone and venous blood gas levels will be measured pre-surgery, post-surgery and on post-operative days until discharge. Our primary research objective is to clarify the expected perioperative ketone and blood gas levels in elective bariatric patients who have been on a VLCD and fasting for surgery, compared to elective surgical patients who have only been fasting prior to surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 5, 2022

Completed
Last Updated

July 5, 2022

Status Verified

June 1, 2022

Enrollment Period

11 months

First QC Date

June 26, 2022

Last Update Submit

June 29, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Blood ketone

    blood ketone levels

    Immediately prior to surgery, immediately post-surgery, daily until discharge until up to 1 week

  • Venous blood gas levels

    Primary outcome measures are blood ketone, and venous blood gas levels.

    Immediately prior to surgery, immediately post-surgery, daily until discharge until up to 1 week

Study Arms (2)

General Surgery

All patients undergoing either elective laparoscopic/open cholecystectomy, laparoscopic/open hiatus hernia repair, laparoscopic/open inguinal hernia repair, laparoscopic/open umbilical hernia repair or laparoscopic ventral wall hernia repair.

Bariatric Surgery

Participants undergoing elective bariatric surgery (laparoscopic sleeve gastrectomy or roux-en-y gastric bypass). Those in the bariatric arm must have been on a VLCD pre operatively

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing either elective laparoscopic/open cholecystectomy, laparoscopic/open hiatus hernia repair, laparoscopic/open inguinal hernia repair, laparoscopic/open umbilical hernia repair or laparoscopic ventral wall hernia repair or elective bariatric procedure will be recruited consecutively. Those in the bariatric arm must have been on a VLCD pre operatively. Recruitment does not require blinding or randomization. Patients will be excluded if they are non-English speaking or cannot consent to the project, if they are already taking an SLGT2 inhibitor or if their procedure was abandoned.

You may qualify if:

  • General surgery group, undergoing the following elective surgeries:
  • laparoscopic/open cholecystectomy
  • laparoscopic/open hiatus hernia repair
  • laparoscopic/open inguinal hernia repair
  • laparoscopic/open umbilical hernia repair
  • laparoscopic ventral wall hernia repair
  • Bariatric surgery group, undergoing the following elective surgeries and a very low calorie diet before surgery:
  • laparoscopic sleeve gastrectomy
  • laparoscopic roux-en-y gastric bypass

You may not qualify if:

  • currently on SLGT2 inhibitor
  • non English speaking
  • procedure abandoned

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Vincent's Hospital Melbourne

Fitzroy, Victoria, 3065, Australia

Location

Related Publications (1)

  • Mollah T, Gillespie C, Cocco A, Taylor L, Chong L, Hii MW. Defining Physiological Ketosis Following Very-Low-Calorie Diets. J Surg Res. 2023 Oct;290:197-202. doi: 10.1016/j.jss.2023.05.001. Epub 2023 Jun 2.

MeSH Terms

Conditions

Diabetes MellitusKetosis

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAcidosisAcid-Base Imbalance

Study Officials

  • Michael Hii, FRACS

    St Vincent's Hospital Melbourne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

June 26, 2022

First Posted

July 5, 2022

Study Start

January 15, 2020

Primary Completion

December 11, 2020

Study Completion

December 12, 2020

Last Updated

July 5, 2022

Record last verified: 2022-06

Locations